REFERENCIAS
  1. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis
    https://n.neurology.org/content/90/17/777
  2. Disease-Modifying Therapies for MS (.pdf)
    https://www.nationalmssociety.org/Programs-and-Services/Resources/The-MS-Disease-Modifying-Medications-(-pdf)
  3. Physician and patient treatment decision-making in relapsing-remitting multiple sclerosis in Europe and the USA
    https://www.futuremedicine.com/doi/10.2217/nmt-2018-0023
  4. Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study
    https://pubmed.ncbi.nlm.nih.gov/32636328/
  5. Evolving concepts in the treatment of relapsing multiple sclerosis
    https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)32388-1/fulltext#seccestitle10
  6. Disease-modifying therapies for multiple sclerosis
    https://www.bmj.com/content/363/bmj.k4674/article-info
  7. Drug Administration
    https://www.merckmanuals.com/home/drugs/administration-and-kinetics-of-drugs/drug-administration
  8. Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies
    https://journals.sagepub.com/doi/10.1177/17562864211019574
  9. Perspectives of Patients with Multiple Sclerosis on Drug Treatment: A Qualitative Study
    https://pubmed.ncbi.nlm.nih.gov/30568564/
  10. Medication Routes of Administration
    https://www.ncbi.nlm.nih.gov/books/NBK568677/
  11. Guide to decision making
    https://mstrust.org.uk/about-ms/ms-treatments/ms-decisions/guide-decision-making
  12. “I Will Respect the Autonomy of My Patient”: A Scoping Review of Shared Decision Making in Multiple Sclerosis
    https://meridian.allenpress.com/ijmsc/article/22/6/285/449979/I-Will-Respect-the-Autonomy-of-My-Patient-A
  13. Route of Administration
    https://www.fda.gov/drugs/data-standards-manual-monographs/route-administration
  14. Evolution of clinical trials in multiple sclerosis
    https://journals.sagepub.com/doi/10.1177/1756286419826547
  15. Treating RRMS
    https://www.nationalmssociety.org/What-is-MS/Types-of-MS/Relapsing-remitting-MS/Treatment
  16. Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity
    https://www.mdpi.com/1422-0067/21/1/143
  17. Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065319/
  18. Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
    https://pubmed.ncbi.nlm.nih.gov/29618493/
  19. What is an MS Relapse?
    https://relapses.mymsaa.org/ms-relapse-overview/what-relapse/
  20. Immunopathology of multiple sclerosis
    https://www.nature.com/articles/nri3871
  21. Multiple sclerosis and cognition: synaptic failure and network dysfunction
    https://www.nature.com/articles/s41583-018-0053-9
  22. Multiple sclerosis
    https://www.nature.com/articles/s41572-018-0041-4
  23. Brain health: time matters in multiple sclerosis
    https://www.msard-journal.com/article/S2211-0348(16)30102-X/fulltext
  24. Remodeling of Axonal Connections Contributes to Recovery in an Animal Model of Multiple Sclerosis
    https://rupress.org/jem/article/200/8/1027/52326/Remodeling-of-Axonal-Connections-Contributes-to
  25. Natural history of multiple sclerosis symptoms
    https://pubmed.ncbi.nlm.nih.gov/24453777/
  26. Clinical Course of Multiple Sclerosis
    https://pubmed.ncbi.nlm.nih.gov/29358317/
  27. Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis
    https://onlinelibrary.wiley.com/doi/abs/10.1002/hbm.22158
  28. Defining the clinical course of multiple sclerosis
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117366/
  29. Slide show: How your brain works
    https://www.mayoclinic.org/brain/sls-20077047
  30. Immune response
    https://medlineplus.gov/ency/article/000821.htm
  31. The impact of quality of life on treatment preferences in multiple sclerosis patients
    https://www.dovepress.com/the-impact-of-quality-of-life-on-treatment-preferences-in-multiple-scl-peer-reviewed-fulltext-article-PPA
  32. Definition of MS
    https://www.nationalmssociety.org/What-is-MS/Definition-of-MS
  33. Fatigue Coping with Fatigue
    https://mymsaa.org/ms-information/symptoms/fatigue/?s_subsrc=google_grant&gclid=EAIaIQobChMIjeW9qoXU8QIVqf_ICh2bwQLCEAAYAiAAEgJYJvD_BwE
  34. Numbness
    https://mymsaa.org/ms-information/symptoms/numbness/
  35. Multiple Sclerosis: Hope Through Research
    https://www.ninds.nih.gov/health-information/patient-caregiver-education/hope-through-research/multiple-sclerosis-hope-through-research#3215_42
  36. Types of MS
    https://www.nationalmssociety.org/What-is-MS/Types-of-MS
  37. Cognitive Health
    https://www.nationalmssociety.org/Living-Well-With-MS/Cognitive-Health
  38. Walking (Gait) Difficulties
    https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms/Walking-Gait-Balance-Coordination
  39. How MS is Diagnosed
    https://www.nationalmssociety.org/Symptoms-Diagnosis/Diagnosing-MS
  40. Managing Relapses
    https://www.nationalmssociety.org/Treating-MS/Managing-Relapses
  41. MS Signs & Symptoms
    https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms
  42. What is Myelin?
    https://www.nationalmssociety.org/What-is-MS/Definition-of-MS/Myelin
  43. Secondary progressive MS (SPMS)
    https://www.nationalmssociety.org/What-is-MS/Types-of-MS/Secondary-progressive-MS
  44. Brain Basics: Know Your Brain
    https://www.ninds.nih.gov/health-information/patient-caregiver-education/brain-basics-know-your-brain?search-term=Brain%20Basics:%20Know%20Your%20Brain
  45. Economic Burden of Multiple Sclerosis and the Role of Managed Care Organizations in Multiple Sclerosis Management
    https://www.ajmc.com/view/cost-effectiveness-multiple-sclerosis-economic-burden
  46. The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
    https://pubmed.ncbi.nlm.nih.gov/28879412/
  47. The notion of “invisibility” in people’s experiences of the symptoms of multiple sclerosis: a systematic meta-synthesis
    https://www.tandfonline.com/doi/full/10.1080/09638288.2020.1741698
  48. Now You See It, Now You Don’t: MS & Invisible Symptoms
    https://www.mscenter.org/education/publications/informs/161-informs-winter-2017/784-now-you-see-it-now-you-don-t-ms-invisible-symptoms
  49. Atlas of MS 2020 – Epidemiology report
    https://www.msif.org/resource/atlas-of-ms-2020/
  50. Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists
    https://www.frontiersin.org/articles/10.3389/fneur.2017.00729/full
  51. Improving Quality of Life in Multiple Sclerosis: An Unmet Need
    https://www.ajmc.com/view/improving-quality-of-life-in-multiple-sclerosis-an-unmet-need

Las recomendaciones de esta página son guías generales para los pacientes:
Dado a que la enfermedad y condición clínica de cada persona es diferente, las orientaciones deben ser validadas por el médico tratante para que estén adaptadas a cada paciente.